R Hunter1, S Barry. 1. Psychiatric Research Institute for Neuroscience in Glasgow, West Medical Building, University of Glasgow, Glasgow G12 8QQ, United Kingdom. robert.hunter@glasgow.ac.uk
Abstract
BACKGROUND: Many patients with schizophrenia suffer from poor social functioning, with high levels of unemployment being one particular consequence. Negative symptoms tend to persist during periods of clinical stability and may have a detrimental effect on function. This paper aims to investigate the relationship between negative symptoms and ability to function. METHODS: The EGOFORS study measured negative symptoms in 295 schizophrenia patients in 11 European sites using the PANSS Negative Subscale and assessment scales for psychosocial function: Global Assessment of Functioning (GAF), Personal and Social Performance (PSP), Quality of Life Scale (QLS), Functional Remission of General Schizophrenia (FROGS), Psychosocial Remission in Schizophrenia (PSRS) and Subjective Wellbeing under Neuroleptics (SWN). The relationships between the PANSS Negative Subscale and the functional scales were investigated, adjusting for differences between study sites. Being in work, duration of illness, age of onset and number of years of education were also investigated for a relationship with function. RESULTS: There were strong, statistically significant correlations between PANSS Negative Subscale and all of the function scales (95% confidence intervals for the correlation coefficients: PSRS 0.77-0.91; FROGS 0.74-0.89; QLS 0.74-0.92; GAF 0.64-0.78; PSP 0.63-0.80) except the SWN. All of the functional scales except SWN were at least moderately related to one another. All of the items in each of the PANSS Negative Subscale and the function scales contributed to the relationships between them. Better functioning correlated strongly with participants being in work. CONCLUSION: This study shows a strong and significant relationship between negative symptoms and psychosocial functioning. Given the impact of negative symptoms on psychosocial function, much more emphasis should be placed on developing effective treatments for negative symptoms, given that most patients with schizophrenia now live in community settings and require to function adequately to support their quality of life.
BACKGROUND: Many patients with schizophrenia suffer from poor social functioning, with high levels of unemployment being one particular consequence. Negative symptoms tend to persist during periods of clinical stability and may have a detrimental effect on function. This paper aims to investigate the relationship between negative symptoms and ability to function. METHODS: The EGOFORS study measured negative symptoms in 295 schizophreniapatients in 11 European sites using the PANSS Negative Subscale and assessment scales for psychosocial function: Global Assessment of Functioning (GAF), Personal and Social Performance (PSP), Quality of Life Scale (QLS), Functional Remission of General Schizophrenia (FROGS), Psychosocial Remission in Schizophrenia (PSRS) and Subjective Wellbeing under Neuroleptics (SWN). The relationships between the PANSS Negative Subscale and the functional scales were investigated, adjusting for differences between study sites. Being in work, duration of illness, age of onset and number of years of education were also investigated for a relationship with function. RESULTS: There were strong, statistically significant correlations between PANSS Negative Subscale and all of the function scales (95% confidence intervals for the correlation coefficients: PSRS 0.77-0.91; FROGS 0.74-0.89; QLS 0.74-0.92; GAF 0.64-0.78; PSP 0.63-0.80) except the SWN. All of the functional scales except SWN were at least moderately related to one another. All of the items in each of the PANSS Negative Subscale and the function scales contributed to the relationships between them. Better functioning correlated strongly with participants being in work. CONCLUSION: This study shows a strong and significant relationship between negative symptoms and psychosocial functioning. Given the impact of negative symptoms on psychosocial function, much more emphasis should be placed on developing effective treatments for negative symptoms, given that most patients with schizophrenia now live in community settings and require to function adequately to support their quality of life.
Authors: David Kimhy; Julia Vakhrusheva; Samira Khan; Rachel W Chang; Marie C Hansen; Jacob S Ballon; Dolores Malaspina; James J Gross Journal: J Psychiatr Res Date: 2014-02-11 Impact factor: 4.791
Authors: Cristina P Garcia; Lauren T Catalano; Kristen R Dwyer; Julie M McCarthy; Melanie E Bennett; Jack J Blanchard Journal: Behav Ther Date: 2018-03-19
Authors: Lisa Hochstrasser; Stefan Borgwardt; Martin Lambert; Benno G Schimmelmann; Undine E Lang; Rolf-Dieter Stieglitz; Christian G Huber Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-03-29 Impact factor: 5.270
Authors: A G Nevarez-Flores; K Sanderson; M Breslin; V J Carr; V A Morgan; A L Neil Journal: Epidemiol Psychiatr Sci Date: 2018-10-01 Impact factor: 6.892
Authors: David Kimhy; Julia Vakhrusheva; Lauren Jobson-Ahmed; Nicholas Tarrier; Dolores Malaspina; James J Gross Journal: Psychiatry Res Date: 2012-06-30 Impact factor: 3.222
Authors: Mark Savill; Stavros Orfanos; Richard Bentall; Ulrich Reininghaus; Til Wykes; Stefan Priebe Journal: Psychiatry Res Date: 2016-11-14 Impact factor: 3.222
Authors: Rashmi Patel; Nishamali Jayatilleke; Matthew Broadbent; Chin-Kuo Chang; Nadia Foskett; Genevieve Gorrell; Richard D Hayes; Richard Jackson; Caroline Johnston; Hitesh Shetty; Angus Roberts; Philip McGuire; Robert Stewart Journal: BMJ Open Date: 2015-09-07 Impact factor: 2.692